Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression
Status:
Completed
Trial end date:
2020-07-15
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to demonstrate the safety of allogeneic islet
transplantation in type 1 diabetic patients performed at the University of Illinois at
Chicago (UIC). The purpose is to reproduce the Edmonton protocol to demonstrate that
pancreatic islets isolated at UIC are safe and of sufficient quality to provide reproducible
graft function.